HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Egermann, U. Articles by Solèr, M. Search for Related Content PubMed PubMed Citation Articles by Egermann, U. Articles by Solèr, M.

Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients?

¹ Pulmonary Division, Dept of Internal Medicine, ² Institute of Pathology and ³ Dept of Cardiothoracic Surgery, University Hospital, Basel, Switzerland

CORRESPONDENCE: M. Solèr, St Claraspital, CH-4016, Basel, Switzerland. Fax: 41 616858469. E-mail: markus.soler@araspital.ch

Keywords: cost effectiveness, lung cancer, post-operative follow-up

Received: April 27, 2001
Accepted October 9, 2001

Even though complete resection is regarded as the only curative treatment for nonsmall cell lung cancer (NSCLC), >50% of resected patients die from a recurrence or a second primary tumour of the lung within 5 yrs. It remains unclear, whether follow-up in these patients is cost-effective and whether it can improve the outcome due to early detection of recurrent tumour.

The benefit of regular follow-up in a consecutive series of 563 patients, who had undergone potentially curative resection for NSCLC at the University Hospital, was analysed. The follow-up consisted of clinical visits and chest radiography according to a standard protocol for up to 10 yrs. Survival rates were estimated using the Kaplan-Meier analysis method and the cost-effectiveness of the follow-up programme was assessed.

A total of 23 patients (6.4% of the group with lobectomy) underwent further operation with curative intent for a second pulmonary malignancy. The regular follow-up over a 10-yr period provided the chance for a second curative treatment to 3.8% of all patients.

The calculated costs per life-yr gained were 90,000 Swiss Francs. The cost-effectiveness of the follow-up protocol was far above those of comparable large-scale surveillance programmes. Based on these data, the intensity and duration of the follow-up was reduced.

This article has been cited by other articles:

				R. Aguilo, F. Macia, M. Porta, M. Casamitjana, J. Minguella, and A. M. Novoa Multiple independent primary cancers do not adversely affect survival of the lung cancer patient Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 1075 - 1080. [Abstract] [Full Text] [PDF]

				J. Rubins, M. Unger, and G. L. Colice Follow-up and Surveillance of the Lung Cancer Patient Following Curative Intent Therapy: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 355S - 367S. [Abstract] [Full Text] [PDF]

				B. Jeremic, J. Classen, and M. Bamberg Regular follow{-}up for patients irradiated for early stage nonsmall{-}cell lung cancer too! Eur. Respir. J., January 1, 2002; 20(4): 1065 - 1066. [Full Text] [PDF]